NGM Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 Apr 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.78% compare to its pairs and should correct upwards.

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer...

Stats
Today's Volume	2.21M
Average Volume	1.07M
Market Cap	128.53M
EPS	$-0.330 ( Q4 \| 2024-03-11 )
Next earnings date	( $0 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.890 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00400 (0.26%)

AADI -2.65%

ABCL 2.41%

ABCM 0.04%

ABEO -1.90%

ABIO -1.69%

ABOS 0.00%

ABSI 2.21%

ABUS -2.13%

ABVX -2.03%

ACAD -0.38%

ACER -17.95%

ACET -5.10%

ACGN 1.29%

ACHL -2.20%

ACHV -1.29%

ACIU -1.50%

ACLX 0.84%

ACRV -4.79%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.25%

ADGI 0.87%

ADIL 0.54%

ADMA -2.54%

ADPT 0.00%

ADTX -3.47%

ADVM -3.40%

ADXN -1.60%

AEON -3.74%

AEZS -2.49%

AFMD -1.05%

AGEN -2.56%

AGIO -2.42%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -1.63%

AKRO -2.28%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -1.51%

ALEC -0.46%

ALGS -1.16%

ALKS 0.04%

ALLK -8.51%

ALLO -4.79%

ALLR -3.37%

ALNA 3.16%

ALNY 1.99%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.46%

ALVR 2.59%

ALXN 0.00%

ALXO -11.26%

ALZN 1.97%

AMRN -0.73%

AMTI -3.13%

ANAB 1.51%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.98%

ANPC -3.15%

APGE -0.96%

APGN 8.48%

APGNW 30.65%

APLM -6.47%

APLS 0.99%

APLT -3.72%

APM -2.94%

APOP 0.38%

APRE 0.60%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.40%

ARDS -14.23%

ARDX 0.00%

ARGX -1.09%

ARNA 0.00%

ARPO -0.90%

ARQT -1.04%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.80%

ARWR -1.60%

ASLN -5.07%

ASMB -8.31%

ASND -1.27%

ATAI -1.11%

ATHA 5.48%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -4.10%

ATXI 1.93%

ATXS -0.33%

AUPH -0.81%

AURA 1.91%

AUTL -1.58%

AVBP -1.06%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.17%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -1.28%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.65%

BCAB 4.58%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.56%

BCTX 8.16%

BCTXW -16.32%

BCYC 1.30%

BDRX -4.94%

BDTX -0.64%

BEAM 1.20%

BFRA -2.91%

BGNE -2.86%

BIOR -5.21%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.19%

BMEA -11.25%

BMRN 0.58%

BNOX 4.61%

BNTC -0.42%

BNTX -1.57%

BOLD -8.47%

BOLT 0.72%

BPMC -0.82%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 33.05%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.46%

CADL -1.31%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA 0.73%

CARM 12.23%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.22%

CCCC -5.21%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.75%

CDMOP 0.04%

CDT -12.20%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.41%

CDXS 7.24%

CELC -3.88%

CELU -0.67%

CELUW 11.80%

CERC -1.68%

CERE -1.01%

CERO -3.40%

CEROW -22.75%

CFRX -27.95%

CGEM -2.13%

CGEN -3.31%

CGON -0.73%

CGTX -4.56%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 0.26%

CINGW 34.95%

CKPT -2.42%

CLBS -16.75%

CLDX -1.96%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 8.55%

CLSD 0.43%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.42%

CMPI 0.00%

CMPX -7.48%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -35.56%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.04%

CORT 2.44%

COYA -1.46%

CPRX -1.06%

CRBP -3.76%

CRBU -4.26%

CRDF -0.44%

CRGX 0.64%

CRIS -1.70%

CRNX -5.74%

CRSP 1.31%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -3.30%

CTNM -2.33%

CTXR 2.84%

CUE 5.57%

CVAC -2.26%

CVKD 0.10%

CWBR 2.80%

CYAD -12.96%

CYCC 8.18%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.85%

CYTO -2.70%

DARE 5.14%

DAWN 0.67%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.32%

DNLI -1.00%

DNTH -9.20%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.11%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 4.68%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 8.02%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.26%

ELYM 1.66%

ENGN -3.45%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 5.16%

ENTA -0.57%

ENTO -2.42%

ENTX 2.08%

ENVB 1.42%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.00%

EXAI -0.95%

EXEL -0.20%

EYEG -0.69%

EYEN 0.95%

EYPT 0.97%

FATE -7.39%

FBIO 0.89%

FBIOP 0.92%

FBLG -15.40%

FBRX -0.04%

FDMT -3.80%

FENC -1.29%

FGEN -4.70%

FHTX 2.67%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.23%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.27%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.09%

GHRS -2.13%

GLMD -5.09%

GLPG -2.26%

GLSI 2.73%

GLTO -0.57%

GLUE -2.51%

GLYC -10.13%

GMAB -0.54%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.91%

GNLX 1.33%

GNPX 0.98%

GNTA 3.94%

GOSS -11.80%

GOVX 4.56%

GOVXW -49.04%

GPCR -6.83%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.32%

GRTX 2.57%

GTHX 0.91%

GUTS -4.98%

GXGXW 41.67%

GYRE -7.21%

HALO -1.17%

HARP 0.09%

HCWB -3.75%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK 0.00%

HOTH -2.70%

HOWL -1.50%

HRMY 0.83%

HRTX 4.26%

HSTO 0.00%

HUMA 0.51%

HUMAW -0.01%

IBRX -3.44%

ICCC 0.22%

ICPT 0.21%

ICU 18.27%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.55%

IFRX -1.80%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB 1.74%

IMCR -2.99%

IMGN 0.02%

IMGO 0.00%

IMMP 5.28%

IMMX -7.33%

IMNM -1.39%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.42%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.56%

INAB -0.01%

INBX 0.46%

INCY -0.90%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 1.92%

INMB 1.95%

INO -2.47%

INSM -1.10%

INTS -2.75%

INVA 0.50%

INZY 1.03%

IOBT -11.02%

IONS 0.26%

IOVA -1.95%

IPA 0.00%

IPHA 5.58%

IPSC -1.56%

IRON -2.68%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.47%

JAGX 1.84%

JANX -3.54%

JAZZ -0.60%

JNCE 0.00%

JSPR -5.96%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.56%

KDNY 0.22%

KMPH -0.34%

KNSA -2.64%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -2.29%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -8.20%

KRTX 0.03%

KRYS -1.01%

KTRA 15.68%

KTTA 8.16%

KTTAW 0.92%

KURA -1.12%

KYMR -2.34%

KYTX -4.25%

KZIA 2.65%

KZR -0.21%

LABP 0.57%

LBPH -2.21%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.18%

LENZ -3.63%

LEXX 0.76%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -10.08%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.65%

LPCN -2.94%

LPTX -1.10%

LQDA -0.57%

LRMR -2.49%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.21%

LXRX -1.76%

LYEL -33.33%

LYRA 1.32%

MACK 0.10%

MBIO -11.82%

MBRX -2.57%

MCRB 2.61%

MDGL -2.76%

MDNA -13.16%

MDWD 0.03%

MDXG -2.50%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.33%

MGX -4.83%

MIRM -1.84%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.06%

MLYS -5.88%

MNKD -0.95%

MNMD 0.57%

MNOV 2.11%

MNPR -5.01%

MOLN 1.79%

MOR 1.20%

MORF -2.60%

MREO -3.57%

MRKR 2.68%

MRNA -5.11%

MRNS -4.04%

MRSN -1.67%

MRTX -0.17%

MRUS 0.28%

MRVI -1.68%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 1.88%

NAMSW 0.43%

NAUT 1.78%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.25%

NKGN 9.24%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.24%

NLSP 7.65%

NLSPW 26.67%

NMRA -1.49%

NMTR -42.97%

NOVN -24.84%

NRBO 11.00%

NRIX -0.50%

NRSN -5.12%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.38%

NTRBW -31.07%

NUVL -1.12%

NVAX -2.11%

NVCT 4.51%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -4.67%

OBSV 0.00%

OCEA -0.70%

OCGN 3.81%

OCS -1.00%

OCUL -1.45%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.63%

OMER -0.51%

OMGA 5.42%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 0.00%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.65%

ORIC -2.97%

ORMP 21.46%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -8.21%

PBYI 1.35%

PCSA 0.00%

PCVX 0.05%

PDSB -3.64%

PEPG 1.85%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.16%

PHIO -0.83%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.92%

PLUR 5.78%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -6.84%

PRAX 1.02%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR 0.00%

PRTA -2.12%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -8.54%

PSTX -0.19%

PTCT -0.51%

PTE -0.82%

PTGX -1.14%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.47%

QLGN -8.22%

QNCX 5.70%

QNRX 0.37%

QSI -11.86%

QSIAW -3.13%

QTTB -1.42%

QURE -0.67%

RAIN -1.63%

RANI 6.42%

RAPT -1.97%

RARE 1.53%

RCKT -7.41%

REGN -0.34%

RENB -3.42%

REPL -2.61%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.19%

RIGL -3.28%

RLAY -3.56%

RLMD 0.33%

RLYB -0.67%

RNA 0.21%

RNAC -5.94%

RNAZ -0.63%

RNXT 0.01%

ROIV -1.66%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.28%

RPTX -2.79%

RUBY 2.70%

RVLP -32.05%

RVMD -0.85%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -2.83%

RYTM -5.45%

RYZB 0.02%

RZLT 0.78%

SABS -1.37%

SABSW -11.81%

SAGE 1.74%

SANA -3.23%

SAVA -0.60%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -4.74%

SEER 1.18%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.90%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.07%

SLGL 4.11%

SLN -4.40%

SLNO -4.12%

SLRX 6.07%

SLS -1.74%

SMMT -2.25%

SNDX 1.51%

SNGX -4.91%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -0.99%

SRRA 0.00%

SRRK -1.73%

SRZN -2.45%

STAB 0.00%

STOK -4.16%

STRO -2.35%

STSA 0.00%

STTK -0.84%

SURF -0.93%

SVRA -4.87%

SWTX 0.52%

SYBX -1.29%

SYRS -1.03%

TALS -0.73%

TARA -6.19%

TARS -0.02%

TBPH 0.48%

TCBP 2.47%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 1.59%

TCRX 0.65%

TECH -0.11%

TENX 1.91%

TERN -7.86%

TFFP -5.33%

TGTX -2.92%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.59%

TNGX -2.70%

TNXP -4.87%

TNYA -4.35%

TPST 2.92%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -22.67%

TSVT -3.18%

TTNP -7.66%

TVTX 1.13%

TYRA -7.13%

UBX -2.13%

UNCY -4.04%

URGN -1.33%

UTHR -0.18%

VACC 11.36%

VALN -2.89%

VAXX 80.94%

VBIV 0.78%

VBLT -8.77%

VCEL -0.23%

VCNX 10.35%

VCYT -0.70%

VERA -3.35%

VERU -0.55%

VERV -2.68%

VIGL 6.32%

VINC 2.96%

VIR 0.98%

VIRI -1.61%

VIRX 2.40%

VKTX -1.25%

VLON -13.04%

VNDA -2.44%

VOR -2.02%

VRCA 0.14%

VRDN -4.00%

VRNA -1.10%

VRPX 0.38%

VRTX 0.43%

VSTM -0.68%

VTGN -1.05%

VTVT -2.97%

VTYX -1.46%

VXRT -2.96%

VYGR -0.51%

VYNE -4.62%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT 1.04%

XCUR 3.58%

XENE -2.68%

XERS 2.14%

XFOR 2.52%

XLO 4.54%

XLRN 0.00%

XNCR 0.67%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.81%

ZNTL -0.36%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-04-05	Tcg Opportunity Iii Gp, Llc	Buy	1 000	Common Stock
2024-04-05	Tcg Opportunity Iii Gp, Llc	Sell	44 000	Common Stock
2024-04-05	Column Group Gp, Lp	Buy	1 000	Common Stock
2024-04-05	Column Group Gp, Lp	Sell	44 000	Common Stock
2024-04-05	Column Group L P	Buy	1 000	Common Stock

INSIDER POWER
-56.91
Last 100 transactions
Buy: 3 241 050 \| Sell: 9 885 031

Correlation (AI algo v.1.1b): Undervalued: 0.78% $1.562 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.36 (neutral)

Short: 0.00 (neutral)

Signal:(48.109) Neutral

NGM Biopharmaceuticals Correlation

10 Most Positive Correlations
EGLE	0.872

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NGM Biopharmaceuticals Correlation - Currency/Commodity

-0.78
( moderate negative )

-0.40
( neutral )

0.00
( neutral )

0.08
( neutral )

NGM Biopharmaceuticals Financials

Annual	2023
Revenue:	$4.42M
Gross Profit:	$2.20M (49.72 %)
EPS:	$-1.730

FY	2023
Revenue:	$4.42M
Gross Profit:	$2.20M (49.72 %)
EPS:	$-1.730

FY	2022
Revenue:	$55.33M
Gross Profit:	$49.35M (89.19 %)
EPS:	$-1.990

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.555

Financial Reports:

No articles found.

NGM Biopharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

NGM Biopharmaceuticals

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trials for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an antagonist antibody that binds GFRAL that is in Phase I/II clinical trials; NGM621, an immunoglobulin 1 monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy; NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced solid tumors; and NGM831 and NGM438 for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck & Co., Inc. to focus primarily on the development of novel medicines for unmet patient needs in retinal and CVM diseases, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.